Cedars-Sinai scientists have created a new experimental drug called TY1 that helps the body repair damaged DNA and restore ...

Scientists have developed TY1, the first-ever drug capable of repairing DNA and regenerating tissue damaged by heart attacks and inflammatory diseases.

Scientists have developed an experimental RNA-based drug, TY1, that repairs DNA, reduces scar tissue and could lead to new ...

Medical Microinstruments (MMI) announced today that the FDA granted 510(k) clearance for its NanoWrist surgical robot ...

MMI’s dissection instruments are some of the smallest fully wristed robotic instruments designed for dissection in open ...

Scientists help mice regain mobility after a stroke using human stem cell transplants, opening up a promising avenue for ...

First U.S. Patient Treated with NanoWrist Dissection Instruments, Marking Early Clinical Adoption and Portfolio Growth ...

MATELASER, INC., a pioneer in mobile laser therapy, today announced the official launch of its global crowdfunding campaign for the W1 REGEN, a breakthrough device that brings clinic-grade laser ...

“Grab a box that puts your knee above your hips. Drive through the heel with a fully extended leg at top to stand and then ...

Merhi reportedly explained a procedure still considered experimental: an injection of platelet-rich plasma, or PRP, into the ...

Trastuzumab deruxtecan (T-DXd; Enhertu), is a HER2-targeting ADC that is used in ET-treated HER2-low or HER2-ultralow disease and offered meaningful results in DESTINY-Breast04. In a 2025 real-world ...